BREA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announced today that it will effect a 1-for-60 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001 per share (“Common Stock”), that will become effective on Feb. 18, 2025, at 12:01 a.m. Eastern Time. The Common Stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under the existing symbol MULN and will begin trading on a split-adjusted basis when the market opens on Feb. 18, 2025. The new CUSIP …

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=129333&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129326&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=129330&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=129320&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=129321&wire=1 or contact Joseph E.

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary effectiveness thresholds.

GILT's fourth-quarter 2024 performance reflects expanding momentum in the defense and IFC sectors, backed by increasing deal wins.

VZ appears to be treading in the middle of the road and investors could be better off if they trade with caution.

With robust financial performance, continued innovation and market leadership, CrowdStrike remains a compelling investment option right now.

QMCO Q3 revenues beat expectations while earnings miss. Top and bottom lines improve year over year, driven by its business transformation and efficiency efforts.

VCYT and NTRS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 13, 2025.

While the top- and bottom-line numbers for Hertz Global (HTZ) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

The headline numbers for Hyatt Hotels (H) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Iron Mountain Incorporated (NYSE:IRM ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Mark Rupe - Senior Vice President of Investor Relations William Meaney - President and Chief Executive Officer Barry Hytinen - Executive Vice President and Chief Financial Officer Conference Call Participants George Tong - Goldman Sachs Nathan Crossett - BNP Eric Luebchow - Wells Fargo Brendan Lynch - Barclays Kevin McVeigh - UBS Andrew Steinerman - JPMorgan Shlomo Rosenbaum - Stifel Jonathan Atkin - RBC Capital Markets Operator Good morning and welcome to the Iron Mountain Fourth Quarter 2024 Earnings Conference Call. All …

Mastercard is bringing its TRACE financial crime-fighting and anti-money-laundering tool to the Asia-Pacific region. TRACE uses “timely and large-scale payments data from multiple financial institutions” to provide intelligence beyond a “financial institution's siloed view,” allowing financial crime tracing across payment networks, according to a Thursday (Feb. 13) news release.

LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Flex Ltd. ("Flex" or "the Company") (NASDAQ:FLEX) for violations of the securities laws.

LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("Icon" or "the Company") (NASDAQ:ICLR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before April 11, 2025.

LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Harmonic Inc. ("Harmonic" or "the Company") (NASDAQ:HLIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.